|
|
| | H-Ser-Ser-Met-Lys-Leu-Ser-Phe-Arg-Ala-Arg-Ala-Tyr-Gly-Phe-Arg-Gly-Pro-Gly-Pro-Gln-Leu-OH Basic information |
| Product Name: | H-Ser-Ser-Met-Lys-Leu-Ser-Phe-Arg-Ala-Arg-Ala-Tyr-Gly-Phe-Arg-Gly-Pro-Gly-Pro-Gln-Leu-OH | | Synonyms: | Catestatin (human) trifluoroacetate salt H-Ser-Ser-Met-Lys-Leu-Ser-Phe-Arg-Ala-Arg-Ala-Tyr-Gly-Phe-Arg-Gly-Pro-Gly-Pro-Gln-Leu-OH trifluoroacetate salt;CATESTATIN (HUMAN);H-Ser-Ser-Met-Lys-Leu-Ser-Phe-Arg-Ala-Arg-Ala-Tyr-Gly-Phe-Arg-Gly-Pro-Gly-Pro-Gln-Leu-OH;Catestatin (human) trifluoroacetate salt;L-Leucine, L-seryl-L-seryl-L-methionyl-L-lysyl-L-leucyl-L-seryl-L-phenylalanyl-L-arginyl-L-alanyl-L-arginyl-L-alanyl-L-tyrosylglycyl-L-phenylalanyl-L-arginylglycyl-L-prolylglycyl-L-prolyl-L-glutaminyl-;Catestatin (human) trifluoroacetate | | CAS: | 197151-46-5 | | MF: | C104H164N32O27S | | MW: | 2326.68 | | EINECS: | | | Product Categories: | | | Mol File: | 197151-46-5.mol |  |
| | H-Ser-Ser-Met-Lys-Leu-Ser-Phe-Arg-Ala-Arg-Ala-Tyr-Gly-Phe-Arg-Gly-Pro-Gly-Pro-Gln-Leu-OH Chemical Properties |
| density | 1.47±0.1 g/cm3(Predicted) | | form | Solid | | color | White to off-white | | Sequence | Ser-Ser-Met-Lys-Leu-Ser-Phe-Arg-Ala-Arg-Ala-Tyr-Gly-Phe-Arg-Gly-Pro-Gly-Pro-Gln-Leu |
| | H-Ser-Ser-Met-Lys-Leu-Ser-Phe-Arg-Ala-Arg-Ala-Tyr-Gly-Phe-Arg-Gly-Pro-Gly-Pro-Gln-Leu-OH Usage And Synthesis |
| Uses | Catestatin human, a catecholamine release-inhibitory peptide, is a pleiotropic peptide involved in cardiovascular protection with its antihypertensive and angiogenic effects. Catestatin human can be used in the study of inflammatory diseases [1]. | | References | [1] Daniel T O'Connor, et al. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens. 2002 Jul;20(7):1335-45. DOI:10.1097/00004872-200207000-00020 |
| | H-Ser-Ser-Met-Lys-Leu-Ser-Phe-Arg-Ala-Arg-Ala-Tyr-Gly-Phe-Arg-Gly-Pro-Gly-Pro-Gln-Leu-OH Preparation Products And Raw materials |
|